208340 — PharmAbcine Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for PharmAbcine, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	97,811	37,844	18,750	19,004	43,350
Net Total Accounts Receivable
Net Total Receivables	1,947	3,230	1,180	1,322	3,270
Total Inventory
Prepaid Expenses
Total Current Assets	100,329	41,651	20,369	20,525	47,038
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5,958	7,205	7,562	1,715	1,615
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	133,553	68,531	40,357	26,696	54,289
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	85,112	14,614	4,443	7,134	3,673
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	87,838	17,618	15,566	10,111	6,598
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	45,715	50,914	24,790	16,585	47,691
Total Liabilities & Shareholders' Equity	133,553	68,531	40,357	26,696	54,289
Total Common Shares Outstanding